StockData
Kairos Pharma, LTD. logo

Kairos Pharma, LTD. (KAPA) stock

KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.44+0.04 (+10.08%)

Close on Nov 18, 2026Market cap $1.64MP/E –Yield –

Kairos Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kairos Pharma's price to book ratio was 2.6× on Nov 11, 2026, against 15.9× a year earlier. Over the last 2 years it ranged from 2.6× to 41.6×, with a median of 13.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.6×−10.9
2025Dec 31, 202513.5×−27.5
2024Dec 31, 202441.0×–

More Kairos Pharma figures

See a number that looks wrong?